tamoxifen and 2-2--azobis(2-amidinopropane)

tamoxifen has been researched along with 2-2--azobis(2-amidinopropane)* in 1 studies

Other Studies

1 other study(ies) available for tamoxifen and 2-2--azobis(2-amidinopropane)

ArticleYear
New 2,6-diaminopyridines containing a sterically hindered benzylphosphonate moiety in the aromatic core as potential antioxidant and anti-cancer drugs.
    European journal of medicinal chemistry, 2019, Dec-15, Volume: 184

    A series of 2,6-diaminopyridines was synthesized for the first time, containing phosphoryl sterically hindered phenolic fragments in the aromatic core. The antioxidant activity of these compounds was investigated, 2,6-diaminopyridine derivatives were shown to exhibit higher activity in comparison with their structural analogues. For dialkyl/diphenyl [(3,5-di-tert-butyl-4-hydroxyphenyl) (2,6-diaminopyridin-3-yl) methyl] phosphonates, their structural analogues based on meta-phenylenediamine, phosphorus-containing sterically hindered phenols and the corresponding cyclohexadienones cytotoxicity against tumor lines of epithelioid carcinoma of the cervix uteri (M-Hela) and breast adenocarcinoma (MCF-7) has been studied in vitro, as well as on normal human Chang liver cell lines. Diphenyl [(3,5-di-tert-butyl-4-hydroxyphenyl) (2,6-diaminopyridin-3-yl) methyl] phosphonate was shown to be the most active against the epithelioid line M-Hela - IC

    Topics: Amidines; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Aspergillus niger; Bacillus cereus; Candida albicans; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Structure; Organophosphonates; Pseudomonas aeruginosa; Pyridines; Staphylococcus aureus; Structure-Activity Relationship

2019